Message from the CEO
Thank you for visiting our website. We appreciate your interest in MAP Pharmaceuticals.
MAP Pharmaceuticals is a product based company that leverages its scientific and clinical expertise to develop and commercialize innovative drugs. Our goal is to improve the quality of life for millions of adults and children around the world who suffer from diseases that we believe are not treated adequately by medicine that is currently available.
MAP Pharmaceuticals focuses on providing patients and physicians with therapies that offer clear, differentiated benefits over existing drugs. Whether it is a faster onset of action, less invasive delivery, or reduced side effects, we are committed to identifying significant undermet needs and opportunities and applying our considerable experience to finding solutions that matter to patients and physicians.
I'm pleased to say we have built this company with exceptionally focused and diligent team members who possess skills spanning the entire spectrum of drug development and commercialization. Together, we have created an environment where innovation, teamwork, integrity and accomplishment are valued and rewarded.
We are now pursuing two late-stage clinical programs in pediatric asthma and migraine. In addition to these programs, we are also using our expertise in small particle development, aerosol formulation and inhalation delivery to expand and grow our product pipeline.
If after reviewing our website you have questions or would like to discuss a certain topic with us, please do not hesitate to contact us directly at info@mappharma.com. Thank you again for your interest in MAP Pharmaceuticals.
Timothy S. Nelson
Chief Executive Officer